Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Indoco Remedies raises renewable energy share to 43.5%, sets 2030 sustainability targets
3+ hour, 53+ min ago (403+ words) Indoco Remedies has increased the share of renewable energy in its total energy consumption to 43.5% in FY2025-26, up from 23.9% a year earlier, as the pharmaceutical company outlined its environmental, social and governance performance in its latest Business Responsibility and Sustainability Report…...
India’s genomics leaders to join Indian Pharma Post E-Conference on August 26
5+ hour, 3+ min ago (288+ words) Delegate registrations are open for a high-level discussion on how genomics is transforming healthcare from reactive treatment to predictive, preventive and personalised care Indian Pharma Post is bringing together leading executives and innovators from India’s genomics, diagnostics and precision medicine…...
LSSSDC’s SkillVerse 2026 discusses workforce skill gaps within life sciences sector
1+ day, 1+ hour ago (429+ words) 100+ senior leaders participate in the National Skill Summit in Hyderabad to address emerging skill gaps, strengthening training ecosystems and building an industry-aligned workforce The Life Sciences Sector Skill Development Council (LSSSDC) hosted SkillVerse 2026, a national skill summit for the life…...
India Health 2026 opens in New Delhi, showcasing healthcare and MedTech innovation
1+ day, 12+ hour ago (470+ words) The three-day exhibition, being held from August 21–23, features more than 300 domestic and international brandsand is expected to attract over 8,000 healthcare and medtech professionals. The event comes as India’s healthcare economy is projected to reach Rs. 110.21 trillion by FY27, according to the…...
Merck and Moderna report landmark Phase 3 success for personalized mRNA melanoma therapy
1+ day, 12+ hour ago (70+ words) The trial met its primary endpoint of recurrence-free survival and a key secondary endpoint of distant metastasis-free survival, marking what the companies describe as the first positive Phase 3 readout Merck Moderna vaccine clinical NATCO Pharma’s Visakhapatnam facility receives 4 observations in…...
Amcor upgrades Illinois facility with advanced automation to bolster healthcare packaging safety
1+ day, 18+ hour ago (74+ words) Indian Pharma Post Amcor upgrades Illinois facility with advanced automation to bolster healthcare packaging safety The Business of Genomics: Opportunities, Investments, and Innovation in India Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants Implementing a digital…...
FDA nod to Ultragenyx gene therapy for rare GSDIa disorder
1+ day, 18+ hour ago (59+ words) GSDIa is caused by pathogenic variants in the G6PC gene NATCO Pharma’s Visakhapatnam facility receives 4 observations in US FDA inspection C2N Diagnostics’ PrecivityAD2 becomes first FDA-cleared Alzheimer’s blood test for adults aged 40+ SNEHA reports significant gains in child and maternal health across Mumbai’s…...
Reliance Foundation Hospital hosts Bandhan of Life to honour organ donors and recipients
1+ day, 21+ hour ago (512+ words) The programme included a session on demystifying organ donation, followed by an interactive FAQ session with doctors Dignitaries, doctors, donor families and organ recipients came together at Bandhan of Life by Sir H. N. Reliance Foundation Hospital to honour the life-saving gift…...
World Hand Surgery Day: Apollo highlights role of timely microsurgery in limb recovery
1+ day, 21+ hour ago (314+ words) Apollo specialists stressed that such injuries should be treated as medical emergencies, with patients requiring immediate reconstructive and microsurgical care Apollo Hospitals, Hyderabad, marked World Hand Surgery Day by honouring patients who have overcome severe hand and upper-limb injuries following…...
Kynexis raises €40 million to push cognition drug toward late-stage trials
1+ day, 18+ hour ago (69+ words) Kynexis has completed enrollment in the Phase 2 study and expects to report topline results by the end of 2026 NATCO Pharma’s Visakhapatnam facility receives 4 observations in US FDA inspection C2N Diagnostics’ PrecivityAD2 becomes first FDA-cleared Alzheimer’s blood test for adults aged 40+ SNEHA reports…...